$ILMN

Global DNA microarray market projected to grow from $2.5B in 2025 to $4.7B by 2034 at 7% CAGR, driven by genomic research and personalized medicine demand.

Global targeted DNA-RNA sequencing market to surge from $8.6B in 2025 to $46.9B by 2035, driven by precision medicine adoption and government genomic initiatives.

Omics clinical trials market grows 8.8% annually from $31.71B in 2025 to $47.78B by 2030, driven by personalized medicine demand and AI advances.

Metafoodx showcases AI food tracking technology at National Restaurant Association Show, claiming 90% waste reduction and 500x ROI for restaurant operators.

Trump signs S. 3971 extending SBIR-STTR programs through 2031. Programs have invested $81 billion supporting 34,000+ small businesses.

Global NGS market projected to reach $29.5B by 2030 from $14.9B in 2025, with Asia-Pacific experiencing fastest growth driven by precision medicine adoption.

Global DNA read, write, edit market projected to surge from $21.4B in 2024 to $67.7B by 2030, driven by CRISPR advances and genomic diagnostics expansion.

Global molecular diagnostics market projected to grow from $18.26B in 2025 to $43.50B by 2035, driven by early disease detection demand and advanced technology adoption.

Global oncology biomarkers market projected to grow from $17.3B (2025) to $33.63B (2030) at 14.3% CAGR, driven by AI, liquid biopsies, and precision medicine adoption.

Sessa Capital invests $175.8M in Sotera Health despite 21% stock decline, signaling value opportunity in the sterilization services provider.

Global molecular diagnostics market projected to reach $33.51B by 2031 at 10.43% CAGR, driven by precision medicine adoption and genomic testing advances.

Global genomics services market projected to grow from $7.94B in 2025 to $25.18B by 2035, driven by rising genetic disorder prevalence and precision medicine initiatives.

Corvex liquidated its $74.5 million MDU Resources stake, shifting capital toward growth stocks like tech and healthcare instead of utilities.

Precision medicine market expected to double to $237.28B by 2031, driven by AI advances and biomarker development at 13.58% annual growth.

SNP genotyping market projected to grow from $8.08B (2026) to $19.48B (2034) at 11.7% annual rate, driven by personalized medicine adoption and genomic technology advances.